(Q35837532)

10 August 2017

Clinical trial of focal segmental glomerulosclerosis in children and young adults (English)

1 reference

focal segmental glomerulosclerosis

10 August 2017

1 reference

1

Debbie S Gipson

1 reference

10 August 2017

18

Norman Siegel

1 reference

10 August 2017

Howard Trachtman

2

1 reference

10 August 2017

Frederick J Kaskel

3

1 reference

10 August 2017

Tom H Greene

4

1 reference

10 August 2017

Milena K Radeva

5

1 reference

10 August 2017

Jennifer J Gassman

6

1 reference

10 August 2017

Marva M Moxey-Mims

7

1 reference

10 August 2017

Ronald J Hogg

8

1 reference

10 August 2017

Sandra L Watkins

9

1 reference

10 August 2017

Richard N Fine

10

1 reference

10 August 2017

Susan L Hogan

11

1 reference

10 August 2017

John P Middleton

12

1 reference

10 August 2017

V Matti Vehaskari

13

1 reference

10 August 2017

Patti A Flynn

14

1 reference

10 August 2017

Leslie M Powell

15

1 reference

10 August 2017

Suzanne M Vento

16

1 reference

10 August 2017

June L McMahan

17

1 reference

10 August 2017

Vivette D D'Agati

19

1 reference

10 August 2017

Aaron L Friedman

20

1 reference

10 August 2017

language of work or name

English

0 references

publication date

6 July 2011

1 reference

10 August 2017

1 reference

10 August 2017

80

1 reference

10 August 2017

868-878

1 reference

10 August 2017

8

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.2011.195

10 August 2017

0 references

cites work

Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of life

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306824

The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306824

Immunosuppressive treatment for focal segmental glomerulosclerosis in adults

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306824

Focal and segmental glomerulosclerosis: definition and relevance of a partial remission

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306824

Mycophenolate mofetil in the treatment of focal segmental glomerulosclerosis.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306824

Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306824

A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306824

Treatment of the idiopathic nephrotic syndrome: regimens and outcomes in children and adults

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306824

Prediction of creatinine clearance from serum creatinine

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306824

A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306824

Mycophenolate mofetil or standard therapy for membranous nephropathy and focal segmental glomerulosclerosis: a pilot study

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306824

Differential risk of remission and ESRD in childhood FSGS.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306824

Primary glomerulonephritis: an update on renal survival and determinants of progression

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3306824

Factors influencing the course and the response to treatment in primary focal segmental glomerulosclerosis

15 November 2018

1 reference

12 December 2020

Focal segmental glomerular sclerosis in adults: presentation, course, and response to treatment

1 reference

12 December 2020

A randomized double-blind placebo-controlled trial of cyclosporine in steroid-resistant idiopathic focal segmental glomerulosclerosis in children

1 reference

12 December 2020

Focal segmental glomerulosclerosis in adult African Americans

1 reference

12 December 2020

Predictive factors of chronic kidney disease in primary focal segmental glomerulosclerosis

1 reference

12 December 2020

Identifiers

DOI

10.1038/KI.2011.195

1 reference

Dimensions Publication ID

10 August 2017

0 references

1 reference

10 August 2017

1 reference